glp-1 agonists and health coaching Agonists: Using Semaglutide, Tirzepatide, Orforglipron for Weight Loss and Obesity Ozempic, And Weight-Loss: A Health
Description
It shows that GLP-1 therapy is no longer only a weight loss conversation
In a large Phase 3 clinical trial published in the New England Journal of Medicine, people who took the highest dose of the Wegovy pill lost an average of 16.6 percent of their body weight after 64 weeks
January 21, 2022
A patient of mine, a veteran who had tried to quit smoking for over a decade, told me that after he started a GLP-1 drug for his diabetes, he lost interest in cigarettes
They target multiple disease pathways at once
According to the World Health Organization, around 422 million people worldwide have diabetes, and 1.5 million deaths are directly attributed to diabetes each year
